A new publication dated October 1, 2026, presents research related to etelcalcetide's therapeutic context in patients on hemodialysis. The study, titled "Efficacy of sequential romosozumab-denosumab therapy in patients on hemodialysis: association with bone mineral density improvement and TRACP-5b rebound," appears in Osteoporosis International, a journal established through cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. The publication is indexed under PubMed ID 42821093. This entry reflects the listed title, journal, and publication date as provided. No specific findings, outcomes, or efficacy conclusions are detailed beyond the title itself. Readers interested in the clinical and regulatory background of etelcalcetide can consult the compound overview for additional context on its approved status and general use.
New Publication Examines Romosozumab-Denosumab Therapy in Hemodialysis Patients
See the full etelcalcetide overview
Source: https://pubmed.ncbi.nlm.nih.gov/42821093/